Ekso Bionics Holdings, Inc.(NASDAQ:EKSO) has been on fire in recent days after the Company announced a collaboration with four leading rehabilitation facilities to establish Centers of Robotic Excellence to help further advance the use of innovative exoskeleton technology for mobility impaired patients.
EKSO traded on the OTCBB for years before uplisting to the NASDAQ stock exchange. The Company was initially called PN Med Group Inc but changed its name to Ekso Bionics Holdings, Inc in December 2013.
Ekso Bionics Holdings, Inc.(NASDAQ:EKSO) has been pioneering the field of robotic exoskeletons, or wearable robots, to augment human strength, endurance and mobility. The company’s first commercially available product called Ekso has helped thousands of people living with paralysis take millions of steps not otherwise possible. By designing and creating some of the most forward-thinking and innovative solutions for people looking to augment human capabilities, Ekso Bionics is helping people rethink current physical limitations and achieve the remarkable.
EKSO is one of the most exciting stocks in small caps and one of the most volatile too making some spectacular moves in recent years. The stock has been weighed down recently by the Company’s new share offering at the end of last year during which EKSO raised $15 million at $1.01 per share.
EKSO trades on the OTCBB but the Company operates more like a Big Board Stock than a microcap. Since inception there has been no known promotion of EKSO yet the stock trades millions. As well the Company has the proven ability to raise large sums of money; EKSO went public through a reverse merger in January of last year, simultaneously raising $20.6 million through a bridge debt transaction.
Originally Berkeley Bionics, Ekso Bionics was founded in Berkeley, California in 2005. Since inception Ekso Bionics has forged partnerships with world-class institutions like UC Berkeley, received research grants from the Department of Defense and licensed technology to the Lockheed Martin Corporation.
For more info on EKSO Please Subscribe below, also you should know we have Something Huge Coming!
Last October EKSO announced that they were selected by Boston Dynamics, now part of Google, to continue developing technologies for Defense Advanced Research Projects Agency’s (DARPA’s) Warrior Web Task A project.
Lockheed Martin is the exclusive contractor of the US military, EKSO is working with them in an attempt to provide exoskeletons for military purposes. Many EKSO investors are overlooking this opportunity. The military market could be the secondary market that not only raises awareness of EKSO’s bionic skeleton, but also advances the function of the technology.
On June 15 EKSO announced a collaboration with four leading rehabilitation facilities to establish Centers of Robotic Excellence to help further advance the use of innovative exoskeleton technology for mobility impaired patients.
As early adopters of state-of-the-art exoskeleton technology, the centers have committed to provide peer-to-peer support as reference sites to train other facilities interested in becoming proficient in innovative approaches to rehabilitation.
“Collaborating with leaders in the rehabilitation community is key to building clinical support on the benefits of exoskeletons to aid early mobility for stroke & spinal cord injury,” said Thomas Looby, president and chief executive officer of Ekso Bionics. “We are proud to work with these visionaries who are dedicated to helping patients with recovery and to provide quantifiable insights into the strides they’re making walking with an exoskeleton.”
We have a Monster Pick Coming. Subscribe Right Now!
Currently trading at a $54 million market valuation EKSO is fully funded moving forward with plenty of cash in the treasury, manageable debt and fast growing revenues. EKSO is also one of the most exciting stocks in small caps fast becoming a leader and pioneering the field of robotic exoskeletons, or wearable robots; their first commercially available product called Ekso has helped thousands of people living with paralysis take millions of steps not otherwise possible. EKSO has a proven ability to raise large sums of money as they prepare for a proposed NASDAQ up-listing. We will be updating on EKSO when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with EKSO.
Sign Up now for our 100% FREE Penny Stock Newsletter
Disclosure: we hold no position in EKSO either long or short and we have not been compensated for this article.